Apollomics, Inc. (APLM) vs Lite Strategy, Inc. (LITS)
A side-by-side comparison of Apollomics, Inc. and Lite Strategy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.47HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
LITS
Lite Strategy, Inc.
$1.40HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — APLM vs LITS
growth of $100 · dividends reinvested · last 1yAPLM +455.4% (+455.4%/yr)LITS -69.1% (-69.1%/yr)APLM compounded faster over this window
Log scale — wide-divergence pair
APLM LITS
APLM vs LITS: by the numbers
- •APLM is the larger company ($49M vs $47M market cap).
- •Both run net losses; LITS's is the smaller (0.00% vs -128.69% net margin).
Metrics side by side
Valuation
| Metric | APLM | LITS |
|---|---|---|
| P/B ratio | N/A | 1.14 |
Profitability
| Metric | APLM | LITS |
|---|---|---|
| Gross margin | 97.00% | 0.00% |
| Operating margin | -111.45% | 0.00% |
| Net margin | -128.69% | 0.00% |
| ROE | N/A | -170.94% |
| ROIC | -2441.49% | -30.75% |
Growth (annualized)
| Metric | APLM | LITS |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
Go deeper
Dig into the metrics
Apollomics ROELite Strategy ROEApollomics operating marginLite Strategy operating marginApollomics revenue growthLite Strategy revenue growthApollomics free cash flowLite Strategy free cash flow
Apollomics & Lite Strategy appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.